IL190583A0 - Pth formulations and methods of use - Google Patents
Pth formulations and methods of useInfo
- Publication number
- IL190583A0 IL190583A0 IL190583A IL19058308A IL190583A0 IL 190583 A0 IL190583 A0 IL 190583A0 IL 190583 A IL190583 A IL 190583A IL 19058308 A IL19058308 A IL 19058308A IL 190583 A0 IL190583 A0 IL 190583A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- pth formulations
- pth
- formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/246,406 US20060052305A1 (en) | 2004-05-10 | 2005-10-06 | Method of treating osteoporosis using intranasal parathyroid hormone |
US11/246,450 US20060052306A1 (en) | 2004-05-10 | 2005-10-06 | GRAS composition for enhanced mucosal delivery of parathyroid hormone |
US11/347,551 US20060127320A1 (en) | 2004-05-10 | 2006-02-03 | Method of delivering parathyroid hormone to a human |
US11/390,940 US20060189533A1 (en) | 2004-05-10 | 2006-03-27 | Stable pharmaceutical dosage forms of teriparatide |
PCT/US2006/013377 WO2007044069A2 (en) | 2005-10-06 | 2006-04-10 | Pth formulations and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
IL190583A0 true IL190583A0 (en) | 2008-11-03 |
Family
ID=39595926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL190583A IL190583A0 (en) | 2005-10-06 | 2008-04-02 | Pth formulations and methods of use |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2009511472A (en) |
KR (1) | KR20080059430A (en) |
CA (1) | CA2625084A1 (en) |
IL (1) | IL190583A0 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3685849A4 (en) * | 2017-09-22 | 2021-12-22 | Asahi Kasei Pharma Corporation | Teriparatide-containing liquid pharmaceutical composition having excellent stability |
US20200289622A1 (en) * | 2017-09-22 | 2020-09-17 | Asahi Kasei Pharma Corporation | Teriparatide-containing liquid pharmaceutical composition having excellent pharmacokinetics and/or safety |
EP3714885B1 (en) | 2017-11-20 | 2024-07-31 | Novmetapharma Co., Ltd. | Composition for preventing, alleviating, or treating bone loss diseases, comprising cyclo(his-pro) (chp) |
KR102115353B1 (en) | 2019-05-17 | 2020-05-26 | 주식회사 노브메타파마 | Composition comprising chp (cyclo-his pro) and pth for preventing, improving or treating of bone loss related disease |
CN114306917A (en) * | 2021-01-12 | 2022-04-12 | 广州新济药业科技有限公司 | Soluble micro-needle patch and preparation method thereof |
-
2006
- 2006-04-10 JP JP2008534515A patent/JP2009511472A/en active Pending
- 2006-04-10 KR KR1020087010885A patent/KR20080059430A/en not_active Application Discontinuation
- 2006-04-10 CA CA002625084A patent/CA2625084A1/en not_active Abandoned
-
2008
- 2008-04-02 IL IL190583A patent/IL190583A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20080059430A (en) | 2008-06-27 |
CA2625084A1 (en) | 2007-04-19 |
JP2009511472A (en) | 2009-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1909644A4 (en) | Inserter and methods of use | |
IL189602A0 (en) | Indenoisoquinolinone analogs and methods of use thereof | |
IL186490A0 (en) | Multicyclic compounds and methods of their use | |
EP1933884A4 (en) | Imaging agents and methods of use thereof | |
EP1945137A4 (en) | Partially covered stent devices and methods of use | |
IL176958A0 (en) | Compounds and methods of use | |
IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
IL213843A0 (en) | 4-aminotetracyclines and methods of use thereof | |
SG10201504801VA (en) | Azaindazole compounds and methods of use | |
ZA200710173B (en) | Tygecycline and methods of preparing 9-nitrominocycline | |
EP1874731A4 (en) | Quinobenzoxazine analogs and methods of using thereof | |
HK1213814A1 (en) | Diclofenac formulations and methods of use | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
EP1899198A4 (en) | Releasable holding mechanism and method of use | |
ZA200804688B (en) | Purine derivatives and methods of use thereof | |
EP1778210A4 (en) | Lipid-amino acid conjugates and methods of use | |
HK1161122A1 (en) | Use of 24-norudca 24-norudca | |
EP1946007A4 (en) | Anbrosteeone derivatives and method of use thereof | |
IL190583A0 (en) | Pth formulations and methods of use | |
EP1812451A4 (en) | Compounds and methods of use thereof | |
EP1906950A4 (en) | Ansamycin formulations and methods of use thereof | |
IL186277A0 (en) | Dnt-maleate and methods of preparation thereof | |
EP1978999A4 (en) | Isolated mcpip and methods of use | |
GB0520930D0 (en) | Composition and method of use | |
ZA200710971B (en) | Elasmobranch-repelling compounds and methods of use |